Ercan, MüjganMungan, SemraGüzel, IşılÇelik, Hüseyin TuğrulBal, CeylanAbuşoğlu, SedatAkbulut, DenizOğuz, Esra FıratYılmaz, Fatma Meriç2020-03-262020-03-262019Ercan, M., Mungan, S., Güzel, I., Celik, H. T., Bal, C., Abusoglu, S., Yilmaz, F. M. (2019). Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke. Advances in Clinical and Experimental Medicine, 28(5), 693-698.1899-5276https://dx.doi.org/10.17219/acem/78360https://hdl.handle.net/20.500.12395/38194Background. Nitric oxide synthase (NOS) is present in the brain and cerebral arteries and it enables the synthesis of nitric oxide (NO), which plays a critical role in brain perfusion. Asymmetrical dimethylarginine (ADMA) is an endogenous NOS inhibitor.en10.17219/acem/78360info:eu-repo/semantics/openAccessnitric oxideasymmetrical dimethylarginineasymmetrical dimethylarginine/arginine levelsarginineacute ischemic strokeArticle28569369830170483Q1WOS:000469774300017Q4